Rituximab is preferable to cyclophosphamide for treatment of membranous nephropathy: COMMENTARY
2021
This is an Early Access article. Please select the PDF button, above, to view it.
Be sure to also read the PRO: 10.34067/KID.0001842021 and the CON: 10.34067/KID.0001432021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI